H. Baas

1.3k total citations
48 papers, 991 citations indexed

About

H. Baas is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, H. Baas has authored 48 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Cognitive Neuroscience. Recurrent topics in H. Baas's work include Parkinson's Disease Mechanisms and Treatments (40 papers), Neurological disorders and treatments (28 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). H. Baas is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (40 papers), Neurological disorders and treatments (28 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). H. Baas collaborates with scholars based in Germany, United States and United Kingdom. H. Baas's co-authors include P.-A. Fischer, Martin Engelhardt, Iris Reuter, Sebastian Harder, Wolfgang H. Oertel, S. Harder, Gerhard Ransmayr, A. G. Beiske, Werner Poewe and Mary S. Jackson and has published in prestigious journals such as Neurology, Medicine & Science in Sports & Exercise and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

H. Baas

48 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Baas Germany 18 752 220 202 115 105 48 991
R. A. C. Roos Netherlands 18 677 0.9× 160 0.7× 278 1.4× 115 1.0× 54 0.5× 36 972
Siegfried Muhlack Germany 19 760 1.0× 153 0.7× 241 1.2× 93 0.8× 45 0.4× 46 981
Diana Paleacu Israel 17 672 0.9× 356 1.6× 272 1.3× 150 1.3× 204 1.9× 26 1.2k
Brandon Barton United States 8 662 0.9× 107 0.5× 231 1.1× 111 1.0× 39 0.4× 17 818
Peter Valkovič Slovakia 20 786 1.0× 255 1.2× 160 0.8× 104 0.9× 126 1.2× 78 1.3k
Jennifer Y. Y. Szeto Australia 12 379 0.5× 161 0.7× 55 0.3× 113 1.0× 170 1.6× 15 625
A. E. Di Rosa Italy 18 573 0.8× 366 1.7× 173 0.9× 107 0.9× 16 0.2× 31 1.1k
Katrin Sikk Estonia 6 379 0.5× 106 0.5× 111 0.5× 79 0.7× 45 0.4× 9 597
Michelle Fullard United States 14 517 0.7× 106 0.5× 105 0.5× 110 1.0× 31 0.3× 30 864
Angus D. Macleod United Kingdom 18 700 0.9× 115 0.5× 156 0.8× 93 0.8× 36 0.3× 41 910

Countries citing papers authored by H. Baas

Since Specialization
Citations

This map shows the geographic impact of H. Baas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Baas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Baas more than expected).

Fields of papers citing papers by H. Baas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Baas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Baas. The network helps show where H. Baas may publish in the future.

Co-authorship network of co-authors of H. Baas

This figure shows the co-authorship network connecting the top 25 collaborators of H. Baas. A scholar is included among the top collaborators of H. Baas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Baas. H. Baas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Thomas, H. Baas, Jan Kassubek, et al.. (2015). Laboratory assessments in the course of Parkinson’s disease: a clinician’s perspective. Journal of Neural Transmission. 123(1). 65–71. 5 indexed citations
2.
Seifried, Carola, Sandra Boehncke, Simon Baudrexel, et al.. (2012). Diurnal Variation of Hypothalamic Function and Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease. Neuroendocrinology. 97(3). 283–290. 40 indexed citations
3.
Schnitzler, Alfons, G. Fuchs, H. Baas, et al.. (2010). Brauchen wir die frühzeitige tiefe Hirnstimulation beim Morbus Parkinson?. Fortschritte der Neurologie · Psychiatrie. 78(S 01). S37–S40. 3 indexed citations
4.
Ebersbach, Georg, et al.. (2006). Scales in Parkinson’s disease. Journal of Neurology. 253(S4). iv32–iv35. 69 indexed citations
5.
Baas, H.. (2006). Pharmakotherapie und Leitlinien: Das Parkinson‐Syndrom. Pharmazie in unserer Zeit. 35(3). 242–248. 1 indexed citations
6.
Baas, H., G. Fuchs, I Gemende, et al.. (2002). Which factors influence therapeutic decisions in Parkinson's disease?. Journal of Neurology. 249(0). 1–1. 1 indexed citations
7.
Baas, H., et al.. (2001). Pharmacokinetic-Pharmacodynamic Relationship of Levodopa with and without Tolcapone in Patients with Parkinson??s Disease. Clinical Pharmacokinetics. 40(5). 383–393. 31 indexed citations
8.
Baas, H. & Peter Schueler. (2001). Efficacy of Cabergoline in Long-Term Use: Results of Three Observational Studies in 1,500 Patients with Parkinson’s Disease. European Neurology. 46(Suppl. 1). 18–23. 25 indexed citations
9.
Baas, H.. (2000). Dyskinesia in Parkinson's disease. Pathophysiology and clinical risk factors. Journal of Neurology. 247(S4). IV12–IV16. 13 indexed citations
10.
Reuter, Iris, S. Harder, Martin Engelhardt, & H. Baas. (2000). The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa. Movement Disorders. 15(5). 862–868. 37 indexed citations
11.
Reuter, Iris, et al.. (1999). Therapeutic value of exercise training in Parkinson???s disease. Medicine & Science in Sports & Exercise. 31(11). 1544–1544. 99 indexed citations
12.
Reuter, Iris, et al.. (1999). Exercise test in Parkinson's disease. Clinical Autonomic Research. 9(3). 129–134. 22 indexed citations
13.
Harder, Sebastian & H. Baas. (1998). Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease *. Clinical Pharmacology & Therapeutics. 64(2). 183–191. 32 indexed citations
14.
Baas, H., A. G. Beiske, Mary S. Jackson, et al.. (1997). Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients. Journal of Neurology Neurosurgery & Psychiatry. 63(4). 421–428. 111 indexed citations
15.
Harder, Sebastian, H. Baas, & Stephan Rietbrock. (1995). Concentration-Effect Relationship of Levodopa in Patients with Parkinson's Disease. Clinical Pharmacokinetics. 29(4). 243–256. 35 indexed citations
16.
Zipp, Frauke, et al.. (1995). Lamotrigine in Parkinson's disease — a double blind study. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 10(2-3). 199–206. 14 indexed citations
17.
Baas, H., et al.. (1993). Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 5(1). 45–61. 32 indexed citations
18.
Zipp, Frauke, H. Baas, & P.-A. Fischer. (1993). Lamotrigine-antiparkinsonian activity by blockade of glutamate release?. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 5(1). 67–75. 33 indexed citations
19.
Fischer, P.-A. & H. Baas. (1987). Preliminary Experience with Madopar HBS: Clinical Observations and Plasma Levodopa Concentrations. European Neurology. 27(1). 81–87. 5 indexed citations
20.
Baas, H., et al.. (1985). Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism. Journal of Neural Transmission. 64(1). 45–54. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. A. C. Roos Breakdown of academic impact, for papers by Siegfried Muhlack Breakdown of academic impact, for papers by Diana Paleacu Breakdown of academic impact, for papers by Brandon Barton Breakdown of academic impact, for papers by Peter Valkovič Breakdown of academic impact, for papers by Jennifer Y. Y. Szeto Breakdown of academic impact, for papers by A. E. Di Rosa Breakdown of academic impact, for papers by Katrin Sikk Breakdown of academic impact, for papers by Michelle Fullard Breakdown of academic impact, for papers by Angus D. Macleod
Rankless by CCL
2026